Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;11(1):1-12.
doi: 10.1002/ehf2.14575. Epub 2023 Nov 10.

Enhancing myocardial function with cardiac contractility modulation: potential and challenges

Affiliations
Review

Enhancing myocardial function with cardiac contractility modulation: potential and challenges

Zihan Li et al. ESC Heart Fail. 2024 Feb.

Abstract

Cardiac contractility modulation (CCM) offers a novel therapeutic avenue for heart failure patients, particularly those unresponsive to cardiac resynchronization therapy within specific QRS duration ranges. This review elucidates CCM's mechanistic underpinnings, its impact on myocardial function, and utility across patient demographics. However, CCM is limited by insufficient data on mortality and hospitalization rate reductions, as well as the need for specialized device implantation skills. While prevailing research has concentrated on left ventricular effects, a knowledge gap persists for other patient subsets. Future inquiries should address combinatory treatment strategies, extended usage and the impact of atrial fibrillation on device implantation. Such expanded studies could refine therapeutic outcomes and widen the scope of beneficiaries.

Keywords: Cardiac contractility modulation; Cardiac devices; Device implantation; Heart failure.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Figure 1
Figure 1
Primary mechanism of CCM in treating HF. CCM enhances cardiac contractility by up‐regulating MHC‐α expression, promoting intracellular calcium handling, and increasing sympathetic nerve activity in the muscles. CCM, cardiac contractility modulation; PLB, phospholamban; SERCA‐2a, sarcoplasmic reticulum calcium ATPase; SR, sarcoplasmic reticulum.
Figure 2
Figure 2
Main changes after 3 months of CCM therapy.
Figure 3
Figure 3
Main mechanism of factors affecting CCM. CCM, cardiac contractility modulation; SR, sarcoplasmic reticulum; PKA, protein kinase A. Ca2+ can be released by SR, which can be promoted by activated CaV1.2 channels; PKA can excite CaV1.2 channels after the action of adrenaline on beta receptors.

Similar articles

Cited by

References

    1. Kurmani S, Squire I. Acute heart failure: Definition, classification and epidemiology. Curr Heart Fail Rep 2017. Oct;14:385‐392. doi:10.1007/s11897-017-0351-y - DOI - PMC - PubMed
    1. Authors/Task Force Members:,McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4‐131. doi:10.1002/ejhf.2333 - DOI - PubMed
    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599‐3726. doi:10.1093/eurheartj/ehab368 - DOI - PubMed
    1. Berliner D, Hänselmann A, Bauersachs J. The treatment of heart failure with reduced ejection fraction. Dtsch Arztebl Int 2020;117:376‐386. doi:10.3238/arztebl.2020.0376 - DOI - PMC - PubMed
    1. Bernard ML, Benn F, Williams CM, Hiltbold AE, Rogers PA, Polin GM, et al. The role of atrial fibrillation catheter ablation in patients with heart failure. Prog Cardiovasc Dis 2021;66:80‐85. doi:10.1016/j.pcad.2021.06.002 - DOI - PubMed